Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125836601 | 12583660 | 1 | I | 20160715 | 20160722 | 20160722 | EXP | US-ETHYPHARM USA CORP-EY-BP-US-2016-035 | ETHYPHARM | 31.00 | YR | M | Y | 0.00000 | 20160722 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125836601 | 12583660 | 1 | PS | SUBUTEX | BUPRENORPHINE HYDROCHLORIDE | 1 | 90622 | 1 | MG | ||||||||||
125836601 | 12583660 | 2 | SS | SUBUTEX | BUPRENORPHINE HYDROCHLORIDE | 1 | Sublingual | 90622 | 2 | MG | |||||||||
125836601 | 12583660 | 3 | SS | KETAMINE | KETAMINE | 1 | 0 | ||||||||||||
125836601 | 12583660 | 4 | SS | METHOXETAMINE (MXE) | METHOXETAMINE | 1 | 0 | ||||||||||||
125836601 | 12583660 | 5 | C | XANAX | ALPRAZOLAM | 1 | 0 | 1 | MG | ||||||||||
125836601 | 12583660 | 6 | C | VALIUM | DIAZEPAM | 1 | 0 | 10 | MG | ||||||||||
125836601 | 12583660 | 7 | C | Albuterol Inhaler | ALBUTEROL | 1 | 0 | ||||||||||||
125836601 | 12583660 | 8 | C | ETIZOLAM | ETIZOLAM | 1 | 0 | ||||||||||||
125836601 | 12583660 | 9 | C | CANNABIS | CANNABIS SATIVA SUBSP. INDICA TOP | 1 | 0 | ||||||||||||
125836601 | 12583660 | 10 | C | CANNABIS INDICA | 2 | 0 | |||||||||||||
125836601 | 12583660 | 11 | C | LSD | LYSERGIDE | 1 | 0 | ||||||||||||
125836601 | 12583660 | 12 | C | 4-HO-MET | 4-HO-MET | 1 | 0 | ||||||||||||
125836601 | 12583660 | 13 | C | ACO-DMT | 2 | 0 | |||||||||||||
125836601 | 12583660 | 14 | C | HEROIN | DIACETYLMORPHINE | 1 | 0 | ||||||||||||
125836601 | 12583660 | 15 | C | Heroin + Methamphetamine + MXE | 2 | 0 | |||||||||||||
125836601 | 12583660 | 16 | C | Benzos | BENZODIAZEPINE | 1 | 0 | ||||||||||||
125836601 | 12583660 | 17 | C | MeO-PCP | 2 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125836601 | 12583660 | 1 | Product used for unknown indication |
125836601 | 12583660 | 3 | Product used for unknown indication |
125836601 | 12583660 | 4 | Product used for unknown indication |
125836601 | 12583660 | 5 | Product used for unknown indication |
125836601 | 12583660 | 6 | Product used for unknown indication |
125836601 | 12583660 | 7 | Asthma |
125836601 | 12583660 | 8 | Product used for unknown indication |
125836601 | 12583660 | 9 | Product used for unknown indication |
125836601 | 12583660 | 11 | Product used for unknown indication |
125836601 | 12583660 | 12 | Product used for unknown indication |
125836601 | 12583660 | 13 | Product used for unknown indication |
125836601 | 12583660 | 14 | Product used for unknown indication |
125836601 | 12583660 | 15 | Product used for unknown indication |
125836601 | 12583660 | 16 | Product used for unknown indication |
125836601 | 12583660 | 17 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125836601 | 12583660 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125836601 | 12583660 | Cystitis | |
125836601 | 12583660 | Drug dependence | |
125836601 | 12583660 | Intentional product misuse | |
125836601 | 12583660 | Intentional product use issue | |
125836601 | 12583660 | Potentiating drug interaction | |
125836601 | 12583660 | Splenic infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |